Register free investing education account       Remember me
	Trading account Review stocks Trading competitions Learn Trading Trading forums Investor Profiles About IE
	- Stocks home   - Register free account   - Trading education Trade stock   Buy this stock Sell short Switch to competitions Changes   HOKU 0.64% 3.15    Buy 0992.HK 0% 5.03    Buy LHCG 0% 23.18    Buy NLST 0% 2.95    Buy OFC --3.27% 37.83    Buy Stock lists   Biggest gainers Biggest losers All gainers All losers Stocks by industry Gains by industry Best stock predictions All stocks Search stock Stocks by sector   Basic Materials Conglomerates Consumer Goods Financial Healthcare Industrial Goods Services Technology Utilities Forum threads   Stock symbol lookup - MNTA Here is some more information available about OFC stock. About the past performance, graphs and links to more detailed analysis. Note that if the markets are closed, the information below can be incorrect. Company name: Momenta Pharmaceu Symbol: MNTA Today's change 0% Open 23.02 Last price 23.08 Time 10:57am Ask 23.10 High 23.25 Bid 23.08 Low 22.56 One year target 27.60 Volume 285897 Last update 2010-07-29, 10:57:00 Click to force this stock to update Click here to see what Zacks has to say about this stock Individual prices within the past 3 days Time Total % Last change Ask Bid 2010-07-27 03:59:00 0% 23 22.71 03:59:00 0% 23 22.71 2010-07-28 04:00:00 0% 23 22.61 2010-07-29 10:57:00 0% 23.1 23.08 Historical stock quote information - MNTA Date Open High Low Close Volume Change You need to be logged in in order to see and post comments. Not registered yet? Register here Company news Report: Sanofi may make $18.7B bid for Genzyme Report: Sanofi may make $18.7B bid for GenzymeMass High TechCambridge-based Momenta Pharmaceuticals succeeded in gaining approval for a generic alternative to a Sanofi drug just last week. ...and more » - G News Sanofi Re -Evaluates US Sales ForceWall Street JournalSandoz, a unit of Switzerland's Novartis AG and partner Momenta Pharmaceuticals Inc. of Boston, won FDA approval last Friday for a generic version of ... - G News Mixed Prognosis for This Big Pharma Stock Mixed Prognosis for This Big Pharma StockMoneyshow.com... for multiple sclerosis that could face a challenge from a generic being developed by Novartis (NYSE: NVS) and Momenta Pharmaceuticals (Nasdaq: MNTA). ...and more » - G News Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call ... Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call ...istockAnalyst.com (press release)Momenta Pharmaceuticals is a biotechnology company, headquartered in Cambridge, MA, specializing in the detailed structural analysis of comp - G News Fighting Hard to Keep a Blockbuster Fighting Hard to Keep a BlockbusterMotley FoolMomenta Pharmaceuticals (Nasdaq: MNTA) fell 12% yesterday, which is a little surprising because the company said on Friday that they had expected the ...and more » - G News Daily Options Trading for Momenta Pharmaceuticals Inc. (MNTA) Daily Options Trading for Momenta Pharmaceuticals Inc. (MNTA)Market IntellisearchNEW YORK (Market Intellisearch) -- Momenta Pharmaceuticals Inc. options saw high put activity today. A total of 5378 put and 893 call contracts were traded ...and more & - G News FDA gives nod to first generic enoxaparin for DVT FDA gives nod to first generic enoxaparin for DVTCardiovascular BusinessApproval of generic enoxaparin sodium injection was granted to Sandoz Pharmaceuticals of Broomfield, Colo. The generic product has been approved in the ...and more » - G News FDA gives nod to first generic enoxaparin for DVT FDA gives nod to first generic enoxaparin for DVTCardiovascular BusinessApproval of generic enoxaparin sodium injection was granted to Sandoz Pharmaceuticals of Broomfield, Colo. The generic product has been approved in the ...and more » - G News Sanofi Sues FDA to Block Approval of Generic Drug Sanofi Sues FDA to Block Approval of Generic DrugSan Francisco Chronicle... a judge to force the FDA to suspend its approval of the generic produced by Novartis AG's Sandoz unit with Momenta Pharmaceuticals Inc.'s technology. ...and more &raq - G News Sanofi Sues FDA to Block Approval of Generic Drug Sanofi Sues FDA to Block Approval of Generic DrugSan Francisco Chronicle... a judge to force the FDA to suspend its approval of the generic produced by Novartis AG's Sandoz unit with Momenta Pharmaceuticals Inc.'s technology. ...and more &raq - G News
	All rights reserved © Investing Education 2010, Email: your [@] investing-education.com / Privacy Policy / Stock symbol lookup MNTA